The current gold standard for T1DM [6] and advanced T2DM [7] patients is to directly inject insulin into the peripheral circulation, bypassing the liver, with the risk of non-physiological hyperinsulinemia [8]. This evidence concerns the gene INS and hyperinsulinism.